Mee Sze Chan
Président chez SHIN HWA WORLD LIMITED
Postes actifs de Mee Sze Chan
Sociétés | Poste | Début | Fin |
---|---|---|---|
SHIN HWA WORLD LIMITED | Président | 18/11/2022 | - |
Directeur/Membre du Conseil | 01/09/2018 | 18/11/2022 | |
The Hong Kong Institute of Chartered Secretaries
The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Corporate Officer/Principal | - | - |
The Chartered Governance Institute
The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | - | - |
Historique de carrière de Mee Sze Chan
Anciens postes connus de Mee Sze Chan
Sociétés | Poste | Début | Fin |
---|---|---|---|
MINGYUAN MEDICARE DEVELOPMENT CO., LTD. | Directeur/Membre du Conseil | 20/05/2016 | 01/01/2020 |
Independent Dir/Board Member | 20/05/2016 | 01/01/2020 | |
OCI INTERNATIONAL HOLDINGS LIMITED | Directeur/Membre du Conseil | 11/04/2011 | 01/09/2018 |
Directeur Général | 11/04/2011 | 06/07/2017 | |
Investor Relations Contact | 11/04/2011 | 04/06/2012 | |
Public Communications Contact | 11/04/2011 | 04/06/2012 | |
Secrétaire Général | 11/04/2011 | 06/07/2017 |
Formation de Mee Sze Chan
University of London | Graduate Degree |
University Of Dundee | Masters Business Admin |
Statistiques
Internationale
Hong Kong | 5 |
Royaume-Uni | 4 |
Opérationnelle
Director/Board Member | 3 |
Corporate Officer/Principal | 2 |
Chief Executive Officer | 1 |
Sectorielle
Commercial Services | 3 |
Consumer Services | 3 |
Finance | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Sociétés cotées | 2 |
---|---|
OCI INTERNATIONAL HOLDINGS LIMITED | Finance |
SHIN HWA WORLD LIMITED | Electronic Technology |
Entreprise privées | 3 |
---|---|
The Hong Kong Institute of Chartered Secretaries
The Hong Kong Institute of Chartered Secretaries Miscellaneous Commercial ServicesCommercial Services The Hong Kong Institute of Chartered Secretaries is an independent professional body that promotes the role of its members in formulating and implementing good governance policies. The private company is based in Hong Kong, Hong Kong. It also aims to develop the profession of chartered secretary and chartered governance professional in mainland China. The institute was established in 1949 as an association of members of the Chartered Governance Institute and gained local status in 1994. It has more than 6,000 members and 3,200 students. | Commercial Services |
The Chartered Governance Institute
The Chartered Governance Institute Miscellaneous Commercial ServicesCommercial Services The Chartered Governance Institute provides governance and compliance services. The company was incorporated by Royal Charter in 1891 and is headquartered in London, the United Kingdom. | Commercial Services |
Mingyuan Medicare Development Co. Ltd.
Mingyuan Medicare Development Co. Ltd. BiotechnologyHealth Technology Mingyuan Medicare Development Co. Ltd. engages in provision of medicare solutions for the early detection and prevention of diseases particularly in China. It operates through the following segments: Protein Chips, Healthcare, Medical Centers Management, Individualized Target Therapy, and Bio-Drugs. The Protein Chips segment manufactures and distributes C-12 products to hospitals, medical centers, and life insurance companies in China. The Healthcare segment engages in the provision of sales and marketing campaign for HPV DNA testing kits and making important progress to register products for distribution to female patients at hospitals nationwide. The Medical Centers Management segment engages in the provision of healthcare services for residents living in cities. The Individualized Target Therapy segment specializes in molecular diagnostic kits for leukemia, lymphoma and individualised target cancer therapy. The Bio-Drugs segment engages in the development, production and commercialization of a new generation of non-specific nanotechnology immunomodulatory drugs known as non-cell Corynebacterium pavum products. The company was founded on May 8, 1989 and is headquartered in Hong Kong. | Health Technology |
- Bourse
- Insiders
- Mee Sze Chan
- Expérience